SCHF vs VHT
Schwab International Equity ETF vs Vanguard Health Care ETF
- • SCHF has the lower expense ratio at 0.03% vs 0.09% for VHT.
- • SCHF pays a higher dividend yield (3.11%).
Side-by-side metrics
| Metric | SCHF | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.03% | 0.09% |
Dividend yield Trailing 12-month yield. | 3.11% | 1.35% |
AUM Assets under management — bigger funds are typically more liquid. | $67.70B | $23.73B |
YTD return | 13.62% | 22.17% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.04 | 0.46 |
P/E ratio | 15.76 | 32.41 |
Last price | $27.18 | $347.68 |
Inception | — | — |
Issuer | Schwab | Vanguard |
SCHF top holdings
| 005930.KQ | Samsung Electronics Co Ltd | 2.68% |
| 000660.KQ | SK hynix Inc | 2.10% |
| ASML.AS | ASML Holding NV | 2.10% |
| SHEL.L | Shell PLC | 1.09% |
| NOVN.SW | Novartis AG Registered Shares | 1.05% |
| HSBA.L | HSBC Holdings PLC | 1.01% |
| RY | Royal Bank of Canada | 0.98% |
| AZN.L | AstraZeneca PLC | 0.97% |
| NESN.SW | Nestle SA | 0.92% |
VHT top holdings
| LLY | Eli Lilly and Co | 12.93% |
| JNJ | Johnson & Johnson | 8.78% |
| ABBV | AbbVie Inc | 6.45% |
| MRK | Merck & Co Inc | 5.01% |
| UNH | UnitedHealth Group Inc | 4.65% |
| TMO | Thermo Fisher Scientific Inc | 3.50% |
| AMGN | Amgen Inc | 3.18% |
| GILD | Gilead Sciences Inc | 2.58% |
| ABT | Abbott Laboratories | 2.40% |
| PFE | Pfizer Inc | 2.27% |
About SCHF
SCHF (Schwab International Equity ETF) is Developed-market equities ex-US. Managed by Schwab, the fund carries $67.7B in assets under management, an expense ratio of 0.03%, a dividend yield of 3.11%. Its largest holding is Samsung Electronics Co Ltd (005930.KQ), which represents 2.7% of the portfolio. Real Estate is the fund's largest sector exposure at 1.9%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $23.7B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.35%. Its largest holding is Eli Lilly and Co (LLY), which represents 12.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.